These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6967148)

  • 1. Molecular basis of B cell activiation--II. Mitogenicity of cardenolide derivatives.
    Hammarström L; Smith CI
    Mol Immunol; 1980 Apr; 17(4):463-8. PubMed ID: 6967148
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between protective immunity, mitogenicity, and B cell activiation by Salmonella vaccines.
    Eisenstein TK; Angerman CR; O'Donnell S; Specter S; Friedman H
    Adv Exp Med Biol; 1979; 121B():39-50. PubMed ID: 397755
    [No Abstract]   [Full Text] [Related]  

  • 3. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.
    Bessler WG; Johnson RB; Wiesmüller K; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans.
    Coutinho A; Möller G; Richter W
    Scand J Immunol; 1974; 3(3):321-8. PubMed ID: 4604786
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between biological activities of polymers. I. Immunogenicity, C3 activation, mitogenicity for B cells and adjuvant properties.
    Diamantstein T; Blitstein-Willinger E
    Immunology; 1975 Dec; 29(6):1087-92. PubMed ID: 1081493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala).
    Bessler WG; Cox M; Wiesmüller KH; Jung G
    Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens.
    Bessler WG; Henning U
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):387-98. PubMed ID: 382663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of B cell activation: mitogenicity of native and modified digitalis glycosides.
    Hammarström LL; Smith CI
    J Immunol; 1978 Mar; 120(3):694-9. PubMed ID: 305443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionophorous activity and murine B lymphocyte mitogens.
    Rosenstreich DL; Blumenthal R
    J Immunol; 1977 Jan; 118(1):129-36. PubMed ID: 299751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective triggering of B cell subpopulations by mitogens.
    Gronowicz E; Coutinho A
    Eur J Immunol; 1974 Nov; 4(11):771-6. PubMed ID: 4609774
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estimation of the effects of cardenolides. 1. Relation between molecular physical parameters and parameters of action of cardenolides].
    Köpke K; Dittrich F; Berlin P
    Pharmazie; 1984 Mar; 39(3):173-6. PubMed ID: 6233620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of membrane stabilizing agents on induction of the immune response. II. Inhibitory effects on lymphocyte activation by B-cell mitogens parallel toxicity.
    Smith CI; Hammarström LL; Waterfield JD
    Scand J Immunol; 1978; 7(2):145-50. PubMed ID: 306664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell activating properties of polymyxin B.
    Smith CI; Hammarström L
    Scand J Immunol; 1978; 7(1):67-72. PubMed ID: 204983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of B lymphocytes by mycoplasma mitogen(s).
    Naot Y; Ginsburg H
    Immunology; 1978 Apr; 34(4):715-20. PubMed ID: 309850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis.
    Coutinho A; Möller G; Anderson J; Bullock WW
    Eur J Immunol; 1973 May; 3(5):299-306. PubMed ID: 4586163
    [No Abstract]   [Full Text] [Related]  

  • 16. Complement-dependent B-cell activation by cobra venom factor and other mitogens?
    Dukor P; Schumann G; Gisler RH; Dierich M; König W; Hadding U; Bitter-Suermann D
    J Exp Med; 1974 Feb; 139(2):337-54. PubMed ID: 4589989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responsiveness of SM/J mice. Cellular characteristics and genetic analysis of hyperresponsiveness to B cell mitogens.
    Engel D; Clark EA; Held L; Kimball H; Clagett J
    J Exp Med; 1981 Sep; 154(3):726-36. PubMed ID: 6974217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of mitogen- and antigen-reactive B lymphocytes on filter paper disks: phenotypic and genotypic analysis of B cell colonies.
    Kelsoe G
    Methods Enzymol; 1987; 150():287-304. PubMed ID: 3501519
    [No Abstract]   [Full Text] [Related]  

  • 19. "B-cell" mitogenicity of carragheenan in mouse.
    Quan PC; Kolb JP; Lespinats G
    Cell Immunol; 1978 Apr; 37(1):1-13. PubMed ID: 306879
    [No Abstract]   [Full Text] [Related]  

  • 20. Chitin: an immunological adjuvant and a polyclonal B-lymphocyte activator.
    Diamantstein T; Klos M; Osawa H; Chen ZC
    Int Arch Allergy Appl Immunol; 1982; 68(4):377-81. PubMed ID: 6980193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.